License to Market Kremezin (drug for chronic renal failure) in Japan - PharmaLive.com (press release) Print
PharmaLive.com (press release)... 2009, under which KUREHA shall grant Mitsubishi Tanabe a license to market Kremezin® in Japan, a drug for chronic renal failure developed by KUREHA.

... read more